Shree Ganesh Remedies Limited (BOM:540737)
India
· Delayed Price · Currency is INR 621.00
+10.40 (1.70%)
At close: Jun 11, 2025
Shree Ganesh Remedies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 1,086 | 1,259 | 902.2 | 712.88 | 490.82 | Upgrade
|
| Other Revenue | - | - | - | -0 | - | Upgrade
|
| Revenue | 1,086 | 1,259 | 902.2 | 712.88 | 490.82 | Upgrade
|
| Revenue Growth (YoY) | -13.74% | 39.54% | 26.56% | 45.24% | -24.22% | Upgrade
|
| Cost of Revenue | 358.74 | 582.33 | 476.45 | 373.11 | 222.11 | Upgrade
|
| Gross Profit | 727.23 | 676.62 | 425.74 | 339.77 | 268.71 | Upgrade
|
| Selling, General & Admin | 101.19 | 97.65 | 69.93 | 48.46 | 73.08 | Upgrade
|
| Other Operating Expenses | 233.92 | 154.78 | 115.67 | 107.22 | 55.76 | Upgrade
|
| Operating Expenses | 430.78 | 311.65 | 220.97 | 189.05 | 156.1 | Upgrade
|
| Operating Income | 296.45 | 364.98 | 204.78 | 150.72 | 112.61 | Upgrade
|
| Interest Expense | -21.07 | -5.45 | -0.45 | -1.05 | -0.3 | Upgrade
|
| Interest & Investment Income | - | 0.65 | 1.35 | 4.17 | 2.66 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 21.46 | 23.34 | 26.58 | 9.64 | Upgrade
|
| Other Non Operating Income (Expenses) | 37.29 | -0.55 | -0.71 | -0.36 | -0.33 | Upgrade
|
| EBT Excluding Unusual Items | 312.68 | 381.08 | 228.3 | 180.05 | 124.29 | Upgrade
|
| Impairment of Goodwill | - | -1.88 | -1.88 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 2.45 | - | - | 5.22 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.05 | 0.19 | - | -0.01 | Upgrade
|
| Asset Writedown | - | - | -0.77 | - | - | Upgrade
|
| Pretax Income | 312.68 | 381.6 | 225.84 | 180.05 | 129.5 | Upgrade
|
| Income Tax Expense | 81.99 | 100.52 | 55.64 | 46.07 | 31.95 | Upgrade
|
| Net Income | 230.68 | 281.08 | 170.2 | 133.99 | 97.54 | Upgrade
|
| Net Income to Common | 230.68 | 281.08 | 170.2 | 133.99 | 97.54 | Upgrade
|
| Net Income Growth | -17.93% | 65.14% | 27.03% | 37.36% | -6.84% | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 12 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 12 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | 2.08% | 2.49% | 0.42% | 1.82% | -0.01% | Upgrade
|
| EPS (Basic) | 17.96 | 22.34 | 13.86 | 10.96 | 8.12 | Upgrade
|
| EPS (Diluted) | 17.96 | 22.34 | 13.86 | 10.96 | 8.12 | Upgrade
|
| EPS Growth | -19.60% | 61.17% | 26.47% | 34.91% | -6.83% | Upgrade
|
| Free Cash Flow | 74.69 | -6.9 | -345.72 | -19.11 | 33.03 | Upgrade
|
| Free Cash Flow Per Share | 5.82 | -0.55 | -28.16 | -1.56 | 2.75 | Upgrade
|
| Dividend Per Share | - | - | 0.500 | 0.500 | 1.458 | Upgrade
|
| Dividend Growth | - | - | - | -65.71% | 30.12% | Upgrade
|
| Gross Margin | 66.97% | 53.74% | 47.19% | 47.66% | 54.75% | Upgrade
|
| Operating Margin | 27.30% | 28.99% | 22.70% | 21.14% | 22.94% | Upgrade
|
| Profit Margin | 21.24% | 22.33% | 18.87% | 18.80% | 19.87% | Upgrade
|
| Free Cash Flow Margin | 6.88% | -0.55% | -38.32% | -2.68% | 6.73% | Upgrade
|
| EBITDA | 392.12 | 420.7 | 240.76 | 184.71 | 140.48 | Upgrade
|
| EBITDA Margin | 36.11% | 33.42% | 26.69% | 25.91% | 28.62% | Upgrade
|
| D&A For EBITDA | 95.67 | 55.73 | 35.98 | 33.99 | 27.87 | Upgrade
|
| EBIT | 296.45 | 364.98 | 204.78 | 150.72 | 112.61 | Upgrade
|
| EBIT Margin | 27.30% | 28.99% | 22.70% | 21.14% | 22.94% | Upgrade
|
| Effective Tax Rate | 26.22% | 26.34% | 24.64% | 25.59% | 24.68% | Upgrade
|
| Revenue as Reported | 1,123 | 1,290 | 933.84 | 748.56 | 511.77 | Upgrade
|
| Advertising Expenses | - | 13.59 | 10.6 | 0.52 | 0.93 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.